2019-11-19
Redwood Pharma AB Quarterly Report January – September 2019
Regulatory
2019-11-12
Last patient completes treatment in RP101 Phase II clinical trial
2019-08-05
Last patient recruited in Redwood Pharma Phase II trial
2019-06-19
Update regarding financial situation
2019-06-18
Update regarding RP101 Phase II trial
2019-02-04
First patient treated in Redwood Pharma Phase II study
2019-01-07
Redwood Pharma receives its third and last national approval
2018-12-14
Redwood Pharma receives approval from another drug authority – the Austrian
2018-11-12
Redwood Pharma initiates clinical trial
2018-10-02
New patent for IntelliGel on the way in the EU